• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Invivyd

Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Invivyd's chair adds CEO role ahead of readout—Chutes & Ladders

Invivyd' chairman becomes CEO. Vertex reshuffles leadership to expand COO role. Inventiva freshens up C-suite ahead of ph. 3 readout.
Marissa Russo , Will Maddox Sep 4, 2026 8:30am
Parachute over beach town

Bavarian Nordic CEO exits after failed takeover—Chutes & Ladders

Mar 6, 2026 8:30am
3D rendering of SARS-CoV-2 virus particles

Invivyd says Pemgarda sequel could be alternative to COVID shots

Jun 26, 2025 10:12am
monoclonal antibody COVID

Invivyd, FDA agree on steps to EUA for COVID monoclonal antibody

Jun 26, 2023 10:36am
change direction new plan alter arrows move reprioritize

Invivyd evolves yet again to keep pace with COVID-19

Mar 6, 2023 10:45am
Layoffs

Invivyd faces C-suite departures, commercial layoffs

Oct 14, 2022 10:29am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings